STOCK TITAN

Optinose to Present at the Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Optinose (NASDAQ:OPTN) will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024. The presentation will be available via webcast on the Optinose website with a replay option for 30 days.
Positive
  • None.
Negative
  • None.

YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531


FAQ

When will Optinose present a company overview and business update?

Optinose will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024.

What time will the presentation take place?

The presentation will take place at 2:15 p.m. ET on April 10, 2024.

Where can I listen to the webcast of the presentation live?

You can listen to the webcast of the presentation live on the Investors page of the Optinose website.

How long will the replay of the webcast be available?

The replay of the webcast will be available for 30 days following the conclusion of the event.

OptiNose, Inc.

NASDAQ:OPTN

OPTN Rankings

OPTN Latest News

OPTN Stock Data

133.95M
82.34M
8.97%
77.6%
2.76%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
YARDLEY

About OPTN

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo